A conference reminder this Thanksgiving weekend: Regular registration for Thrombosis Unpacked: Decisions That Matter closes October 14. Join us in Montréal on November 7 or access the full conference on demand afterward. thrombosiscanada.ca/2026Conference
Heme/Onc
by @moderation.medsky.network
A Medsky feed for healthcare workers in the fields of hematology & oncology. Keywords include oncsky, hemesky, oncology, hematology, cancersky. Users with any of @medsky.social's heme/onc labels will be added to curation list. Posts in reverse chronological order.
A concise summary of the current management of genitourinary trauma prepared for the Journal of Trauma and Acute Care Surgery – What you need to know. https://www.ovid.com/jnls/jtrauma/fulltext/10.1097/ta.0000000000005051~genitourinary-trauma-what-you-need-to-know
Join us in #SanDiego on October 24 for a FREE myeloma workshop. Ask experts your questions, learn about myeloma care, and connect with others in your community. Register today at https://mmsm.link/4tbRFKj
October is Breast Cancer Awareness Month. Learn about risk factors, symptoms and more. https://bit.ly/3mvfzzQ #BreastCancerAwarenessMonth #BreastCancer
Barrel Chest 🫁 A barrel chest has an increased front-to-back diameter, giving the chest a rounded appearance. It can develop with chronic lung hyperinflation, classically seen in emphysema, but does not diagnose COPD on its own. Have you seen this finding on physical exam? Share below 👇 🔗 Link:
To overcome tumor immune evasion, researchers engineered NK cells that target PD-L1, block NKG2A/HLA-E inhibitory signaling, and produce IL15 to improve antitumor activity, survival, and metabolic fitness. #OpenAccess: doi.org/10.1038/s413... #TumorImmunology #CellTherapy #ImmunoOncology
A urine methylation assay for #UrothelialCarcinoma demonstrated high sensitivity and specificity and showed higher sensitivity than urine cytology and fluorescence in situ hybridization. ja.ma/3TOAkLC
🧠 Migraine is a chronic neurological disorder that affects over 1 billion people globally each year, with women predominantly affected. A new Seminar discusses typical symptoms, mechanisms, and treatment options: spkl.io/633257VNQH
How do we help patients truly understand their care? BRIDGE brings expert faculty + patient perspectives together for 2 days of hands-on learning in Durham, NC. No-charge registration, up to 13 CE credits. https://site.aapm.org/bridge
#Familial #hypercholesterolaemia is an autosomal, semi-dominant condition characterised by markedly elevated plasma #LDL #cholesterol concentration from birth, xanthomas, & early onset of #atherosclerotic #cardiovascular disease (#ASCVD) thelancet.com/journals/lan... #HeFH #HoFH #EndoSky #CardioSky
Missed out when the Cambridge Half Marathon sold out? Good news, we have a few Kidney Care UK places available! This is your chance to be part of an incredible event and make every mile count for people affected by kidney disease 👉 kidneycareuk.org/kidney-care-uk-events/ttp-cambridge-half-marathon
🩸 This Month on HemeHub: Acute Hepatic Porphyria Explore diagnosis, acute attacks, common triggers, and treatments including IV hemin and givosiran. 🌐 Learn more: hemehub.org #AcuteHepaticPorphyria #Porphyria #Hematology #HemeHub
🌟 Stay up to date with HemeHub and other specialty-focused hubs through the ClinEdPulse app. Explore webinars, recorded sessions, events, workshops, and expert-led medical education across specialties. 📲 Available on the App Store 🌐 clinedpulse.org #ClinEdPulse #HemeHub #MedicalEducation #MedEd
🩸 Explore what’s ahead for HemeHub in 2027! The upcoming year’s live webinar schedule is now available on our website! 🌐 Learn more: hemehub.org/live-webinars #HemeHub #Hematology #HemeOnc #MedEd
Risk Factors and Outcomes of Vancomycin-Resistant Enterococcus faecium Bloodstream Infection in Hematologic Malignancies and Stem Cell Transplant Recipients: A Case-Control Study ✅ Just Accepted 🔗 https://bit.ly/4e7Jt95
Join the next IDSA Foundation Bartlett webinar on Mon. Oct. 19 at 1pm ET to explore RSV prevention products and approaches to implementing monoclonal antibody prevention in birth hospital and outpatient settings, in partnership with @pidsociety.bsky.social. Register: https://bit.ly/4dSTJlt
Translational and phase I evaluation of AZD0292, a novel, half-life extended anti-Pseudomonal Psl-PcrV bispecific monoclonal antibody ✅ Just Accepted 🔗 https://bit.ly/4ekWUm3
The latest myeloma news, all in one place. Find research updates, expert interviews, and more on SOHO Insider, including coverage from SOHO 2026. Go to sohoinsider.com/category/mul... #MultipleMyeloma #Hematology #SOHO2026